Amanote Research
Register
Sign In
P2.01-12 Ramucirumab+Docetaxel Usage Following Rapid Disease Progression in Real World Advanced Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1066
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
M. Batus
C. Molife
J. Clarke
V. Stefaniak
K. Winfree
Z. Cui
Y. Han
M. Tawney
P. Bonomi
Publisher
Elsevier BV
Related search
P3.01-19 Sequencing of Ramucirumab+Docetaxel Post-Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Real‐world Progression, Treatment, and Survival Outcomes During Rapid Adoption of Immunotherapy for Advanced Non–small Cell Lung Cancer
Cancer
Cancer Research
Oncology
P2.01-41 the Role and Mechanism of FBW7 Deficiency in Advanced Non-Small Cell Lung Cancer With Docetaxel Resistance
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Randomized, Double-Blind, Phase II Study of Ramucirumab Plus Docetaxel vs Placebo Plus Docetaxel in Japanese Patients With Stage IV Non-Small Cell Lung Cancer After Disease Progression on Platinum-Based Therapy
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Docetaxel Monotherapy as Second-Line Treatment for Pretreated Advanced Non-Small Cell Lung Cancer Patients
Korean Journal of Internal Medicine
Internal Medicine
Advanced Non-Small Cell Lung Cancer in Elderly Patients
Breathe
Pulmonary
Respiratory Medicine
Pcn61 - Real-World Progression-Free Survival of Patients With Advanced Non-Small Cell Lung Cancer: Results of a Claims Data Study of Patients in Germany
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
P2.01-131 Apatinib as an Alternative for Advanced Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Molecular Testing for Stage IV Non–Small Cell Lung Cancer Patients With Targetable Mutations Following Disease Progression
Archives of Pathology and Laboratory Medicine
Medicine
Forensic Medicine
Pathology
Medical Laboratory Technology
